Nevertheless, AD can sometimes have a different morphology (ie, a nummular, prurigo-like, or seborrheic dermatitis–like morphology) and can occur with normal levels of total and allergen ...
GD2-CART01 is under clinical development by Bellicum Pharmaceuticals and currently in Phase I for Pediatric Diffuse Intrinsic Pontine Glioma. According to GlobalData, Phase I drugs for Pediatric ...
Dordaviprone hydrochloride is under development for the treatment of high-grade glioma including thalamus, meningioma, hypothalamus, brainstem, cerebellum, midbrain, or spinal cord, diffuse midline ...
The prevalence of atopic diseases in relatives was significantly higher among EAD subjects than among IAD subjects.
At the heart of successful investing lies the concept of intrinsic value—the true worth of a stock based on its fundamentals. This metric serves as a compass for investors, pinpointing undervalued ...
Approximately 20-30% of people who seek medical attention for vulvar concerns have vulvar dermatitis. Atopic dermatitis—a type of eczema—is caused by a combination of genetic (inherited ...
There is no cure for atopic dermatitis (eczema), but there are treatments that can help manage this common inflammatory skin condition. Regardless of the stage of the disease, self-care is important ...
The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the topical treatment of atopic dermatitis in adult and pediatric patients ...
The Food and Drug Administration (FDA) has approved Vtama ® (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for the topical treatment of atopic dermatitis in adults and pediatric patients ...
The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older. The approval is ...